Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer

  1. Rugo, H.S.
  2. Tolaney, S.M.
  3. Loirat, D.
  4. Punie, K.
  5. Bardia, A.
  6. Hurvitz, S.A.
  7. O’Shaughnessy, J.
  8. Cortés, J.
  9. Diéras, V.
  10. Carey, L.A.
  11. Gianni, L.
  12. Piccart, M.J.
  13. Loibl, S.
  14. Goldenberg, D.M.
  15. Hong, Q.
  16. Olivo, M.
  17. Itri, L.M.
  18. Kalinsky, K.
Revue:
npj Breast Cancer

ISSN: 2374-4677

Année de publication: 2022

Volumen: 8

Número: 1

Type: Article

DOI: 10.1038/S41523-022-00467-1 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus